TY - JOUR
T1 - Delphi Consensus on the Management of Patients With Advanced COPD
T2 - COPD-Avanz Working Group
AU - COPD-Avanz Working Group
AU - Figueira Gonçalves, Juan Marco
AU - de Miguel Díez, Javier
AU - Alcázar Navarrete, Bernardino
AU - Almagro Mena, Pere
AU - Alonso-Ortiz, María Belén
AU - Balañá Corberó, Ana
AU - Barrecheguren, Miriam
AU - Cabestre García, Roberto
AU - Cases Viedma, Enrique
AU - Cejudo Ramos, Pilar
AU - Fernández-Villar, Alberto
AU - Golpe, Rafael
AU - Iriberri Pascual, Milagros
AU - López-Campos, José Luis
AU - Molina París, Jesús
AU - de la Rosa-Carrillo, David
AU - Sayas Catalán, Javier
AU - Miravitlles, Marc
N1 - Publisher Copyright:
© 2025 Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
PY - 2025/4/1
Y1 - 2025/4/1
N2 - Introduction: To reach a multidisciplinary consensus on the management of patients with advanced COPD using Delphi methodology. Material and methods: A multidisciplinary committee of experts (Pneumology, Physiotherapy, Internal Medicine, Physical Medicine and Rehabilitation, Primary Care, and Nursing) developed a 105-item questionnaire to be agreed by a panel of experts grouped into the following topics: (1) Definition of advanced COPD patients; (2) Management of dyspnoea in patients with advanced COPD; (3) Prevention and recovery of exacerbation in patients with advanced COPD; and (4) Dealing with disease progression. Results: After two rounds, consensus was reached on 77.1% of the items. The definition proposed for advanced COPD and agreed by 91.5% of the panellists stated: “COPD patient with FEV1 < 50% and at least two of the following criteria: dyspnoea mMRC 3–4, chronic respiratory insufficiency, and limitation in basic activities of daily living”. Other relevant agreements were: the use of opioids, pulmonary rehabilitation and respiratory physiotherapy, or home high-flow therapy and long-term oxygen therapy for the improvement of dyspnoea; the role of comorbidities assessment; the inclusion of these patients in respiratory rehabilitation programmes; the use of inhaled antibiotic treatment in chronic bronchial infection by Pseudomonas aeruginosa in the prevention and recovery of exacerbations; and the criteria for lung transplantation or augmentation therapy in patients with advanced COPD and severe α1-antitrypsin deficiency. Conclusions: In this document, a broad panel of experts reached a high degree of consensus on the definition of advanced COPD as well as on its approach. The information provided by this consensus is intended to assist the clinician in the identification of these patients as well as to provide guidance on their management.
AB - Introduction: To reach a multidisciplinary consensus on the management of patients with advanced COPD using Delphi methodology. Material and methods: A multidisciplinary committee of experts (Pneumology, Physiotherapy, Internal Medicine, Physical Medicine and Rehabilitation, Primary Care, and Nursing) developed a 105-item questionnaire to be agreed by a panel of experts grouped into the following topics: (1) Definition of advanced COPD patients; (2) Management of dyspnoea in patients with advanced COPD; (3) Prevention and recovery of exacerbation in patients with advanced COPD; and (4) Dealing with disease progression. Results: After two rounds, consensus was reached on 77.1% of the items. The definition proposed for advanced COPD and agreed by 91.5% of the panellists stated: “COPD patient with FEV1 < 50% and at least two of the following criteria: dyspnoea mMRC 3–4, chronic respiratory insufficiency, and limitation in basic activities of daily living”. Other relevant agreements were: the use of opioids, pulmonary rehabilitation and respiratory physiotherapy, or home high-flow therapy and long-term oxygen therapy for the improvement of dyspnoea; the role of comorbidities assessment; the inclusion of these patients in respiratory rehabilitation programmes; the use of inhaled antibiotic treatment in chronic bronchial infection by Pseudomonas aeruginosa in the prevention and recovery of exacerbations; and the criteria for lung transplantation or augmentation therapy in patients with advanced COPD and severe α1-antitrypsin deficiency. Conclusions: In this document, a broad panel of experts reached a high degree of consensus on the definition of advanced COPD as well as on its approach. The information provided by this consensus is intended to assist the clinician in the identification of these patients as well as to provide guidance on their management.
KW - Chronic obstructive pulmonary disease
KW - COPD
KW - Diagnosis
KW - End of life
KW - Treatment
UR - https://www.scopus.com/pages/publications/85218997811
U2 - 10.1016/j.opresp.2025.100411
DO - 10.1016/j.opresp.2025.100411
M3 - Article
AN - SCOPUS:85218997811
SN - 2659-6636
VL - 7
JO - Open Respiratory Archives
JF - Open Respiratory Archives
IS - 2
M1 - 100411
ER -